Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.84% | -25.02% | -24.04% | -14.79% | -0.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.84% | -25.02% | -24.04% | -14.79% | -0.82% |
| Cost of Revenue | -54.27% | 0.22% | 3.02% | 14.48% | 37.50% |
| Gross Profit | 2,304.01% | -86.92% | -95.21% | -96.03% | -106.71% |
| SG&A Expenses | -54.26% | -63.13% | -65.84% | -56.64% | -40.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.02% | -53.05% | -54.47% | -45.17% | -30.21% |
| Operating Income | 72.44% | 62.67% | 63.24% | 52.98% | 36.89% |
| Income Before Tax | 71.61% | 63.60% | 63.12% | 51.82% | 39.75% |
| Income Tax Expenses | 900.00% | 281.82% | 222.22% | -46.77% | -100.21% |
| Earnings from Continuing Operations | 71.58% | 63.58% | 63.10% | 51.82% | 40.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.58% | 63.58% | 63.10% | 51.82% | 40.26% |
| EBIT | 72.44% | 62.67% | 63.24% | 52.98% | 36.89% |
| EBITDA | 79.35% | 71.13% | 70.51% | 58.96% | 42.16% |
| EPS Basic | 88.48% | 85.03% | 84.09% | 77.07% | 64.87% |
| Normalized Basic EPS | 95.70% | 88.70% | 85.15% | 76.72% | 51.40% |
| EPS Diluted | 88.48% | 85.03% | 84.09% | 77.08% | 64.87% |
| Normalized Diluted EPS | 95.70% | 88.70% | 85.15% | 76.72% | 51.40% |
| Average Basic Shares Outstanding | 220.01% | 183.28% | 160.18% | 123.36% | 94.60% |
| Average Diluted Shares Outstanding | 220.01% | 183.28% | 160.18% | 123.36% | 94.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |